Generate Biomedicines, Inc. (GENB)
Generate Biomedicines will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet
Generate Biomedicines Revenue
In the year 2025, Generate Biomedicines had annual revenue of $31.89M with 55.89% growth.
Revenue (ttm)
$31.89M
Revenue Growth
+55.89%
P/S Ratio
n/a
Revenue / Employee
$102,221
Employees
312
Market Cap
n/a
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 31.89M | 11.43M | 55.89% |
| Dec 31, 2024 | 20.46M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionGENB News
- 5 hours ago - Generate Biomedicines Begins IPO Push With Major Collaboration Deals - Seeking Alpha
- 2 days ago - Generate Biomedicines, Clinical-Stage Generative Biology Company Designing AI-Engineered Protein Therapeutics, Files for Nasdaq IPO - TradingView News
- 2 days ago - Generate Biomedicines IPO Registration Document (S-1) - SEC
- 2 days ago - Asthma-focused AI biotech Generate Biomedicines files for a $100 million US IPO - Renaissance Capital